荣昌生物与参天中国达成超12亿元合作 公司连续亏损压力待解

新京报
Aug 20, 2025

8月19日,荣昌生物制药(烟台)股份有限公司(简称“荣昌生物”)发布公告,公司与日本参天制药株式会社全资子公司参天制药(中国)有限公司(简称“参天中国”)签署授权许可协议,就荣昌生物自主研发的RC28-E注射液展开合作。此次合作,将为亏损中的荣昌生物带来一笔合计超12亿元的里程碑付款及梯度销售分成。  合作将获超12亿元收益  根据协议,荣昌生物将RC28-E注射液有偿许可给参天中国,参天中国获得...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10